CMS announced a new funding opportunity for development, improvement and expansion of quality measures for the Quality Payment Program. Over three years, the agency will provide up to $30 million in ...
The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...